Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
H3Africa Consortium | RCV001777167 | SCV002014646 | benign | not specified | 2020-10-28 | criteria provided, single submitter | research | While the frequency of the alternate allele in gnoMAD v2.0.2 is 0.896, its frequency in African populations is >5%. This suggests that previous classifications of this variant as pathogenic are in error. |
Breakthrough Genomics, |
RCV004714028 | SCV005287968 | benign | not provided | criteria provided, single submitter | not provided | ||
Fujian Institute of Hematology, |
RCV000509081 | SCV000577911 | pathogenic | Acute myeloblastic leukemia with maturation | no assertion criteria provided | case-control | This variant contributes to development of AML-M2 |